Divergent in situ expression of IL‐31 and IL‐31RA between bullous pemphigoid and pemphigus vulgaris

Ergun, Ecem Zeliha ; Aoki, Rui ; Horváth, Orsolya N.; Hartmann, Daniela ; Satoh, Takashi K. ; Calabrese, Laura ; Aksu, Ayşe Esra Koku; Gürel, Mehmet Salih; Manav, Vildan; Flaig, Michael J.; Sárdy, Miklós ; Ruzicka, Thomas; French, Lars E. und Bağcı, Işın Sinem (2023): Divergent in situ expression of IL‐31 and IL‐31RA between bullous pemphigoid and pemphigus vulgaris. In: Experimental Dermatology, Vol. 32, No. 9: pp. 1412-1419

Abstract

Bullous pemphigoid (BP) and pemphigus vulgaris (PV) are two major autoimmune blistering skin diseases. Unlike PV, BP is accompanied by intense pruritus, suggesting possible involvement of the pruritogenic cytokine IL-31. However, the underlying mechanisms of the clinical difference between BP and PV in terms of pruritus are not fully understood. To compare the expression levels of IL-31 and its receptor IL-31RA in the lesional skin, including peripheral nerves in BP and PV patients, immunohistochemical staining for IL-31 and IL-31RA was performed in skin samples of BP and PV patients and healthy controls (HC). The IL-31RA-expressing area in epidermis and peripheral nerves was analysed using ImageJ and the percentage of positive cells for IL-31/IL-31RA in dermal infiltrating cells was manually quantified. Quantitative analyses revealed that IL-31/IL-31RA expressions in the epidermis and dermal infiltrate were significantly increased in BP compared to PV and HC. The difference between BP and PV became more obvious when advanced bullous lesions were compared. Peripheral nerves in BP lesions presented significantly higher IL-31RA expression compared to PV lesions. In conclusion, we found significantly augmented expressions of IL-31/IL-31RA in BP lesions, including peripheral nerves, in comparison to PV. These results suggest a possible contribution of IL-31/IL-31RA signalling to the difference between BP and PV in the facilitation of pruritus and local skin inflammation, raising the possibility of therapeutic targeting of the IL-31/IL-31RA pathway in BP patients.

• Item Type: Journal article
• Faculties: Medicine > Medical Center of the University of Munich > Clinic and Polyclinic for Dermatology and Allergology
• Subjects: 600 Technology > 610 Medicine and health
• ISSN: 0906-6705
• Language: English